VANCOUVER - InMed Pharmaceuticals Inc. (NASDAQ: INM), a small-cap biotech company with a market capitalization of $2.21 million, has announced the selection of an intravitreal (IVT) formulation, ...
SYDNEY, Australia - Immutep Limited (NASDAQ:IMMP), a biotechnology company specializing in pharmaceutical preparations with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback